ArrowMark Colorado Holdings LLC 13D/13G Filings for Xeris Biopharma Holdings, Inc. (XERS)

ArrowMark Colorado Holdings LLC 13D and 13G filings for Xeris Biopharma Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
1:29 pm
Purchase
2020-12-31 13G Xeris Biopharma Holdings, Inc.
XERS
ArrowMark Colorado Holdings LLC 1,981,909
3.300%
53,601increase
(+2.78%)
Filing